Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate (Q30838883)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate |
scientific article |
Statements
1 reference
Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate (English)
1 reference
Christopher A Salvatore
1 reference
James C Hershey
1 reference
Halea A Corcoran
1 reference
John F Fay
1 reference
Victor K Johnston
1 reference
Eric L Moore
1 reference
Scott D Mosser
1 reference
Christopher S Burgey
1 reference
Daniel V Paone
1 reference
Anthony W Shaw
1 reference
Samuel L Graham
1 reference
Joseph P Vacca
1 reference
Theresa M Williams
1 reference
Kenneth S Koblan
1 reference
Stefanie A Kane
1 reference
26 November 2007
1 reference
324
1 reference
416-421
1 reference
Identifiers
1 reference
1 reference